What is Multiple Sclerosis?

Multiple sclerosis is a disease in which the myelin sheath that protects axons are damaged. Axons relay messages between the brain, spinal cord, and different parts of the body. Symptoms can occur in different parts of the body since nerve damage can occur anywhere. Numbness and loss of balance are common symptoms.

There is no cure for multiple sclerosis; however, there are medications that can be taken to slow down multiple sclerosis. Common drug classes used to treat multiple sclerosis are GABA agonists, integrin antagonists, interferon betas, topoisomerase inhibitors, NMDA receptor antagonist / antiarrhythmic combinations, adrenocorticotropic hormones, and potassium channel blockers.

Savings Tips for Multiple Sclerosis

  • New Multiple Sclerosis Drug Zinbryta Approved

    July 01, 2016

    The Multiple Sclerosis Foundation estimates that more than 400,000 people in the United States have been diagnosed with MS. There is no cure for multiple sclerosis (MS), but there are treatments available that can slow down its progression or treat symptoms.

    The FDA recently approved a new option for relapsing forms of multiple sclerosis: Zinbryta (daclizumab).

    Is there anything unique about Zinbryta?

    Yes. See More

  • New Copaxone Generic Launched! Look for Glatopa in Pharmacies Soon

    June 26, 2015

    Glatopa, the new generic alternative to multiple sclerosis (MS) treatment Copaxone, was approved earlier this year, and its launch has been anxiously awaited. Now, the time has come, and Glatopa will be available in pharmacies soon!

    Manufacturer Sandoz announced last Thursday, June 18, that Glatopa has began shipping following its recent FDA approval.

    Is Glatopa an FDA approved generic?

    Yes. Glatopa has been approved by the FDA as a substitutable generic for the brand-name drug CopaxoneSee More

  • New Copaxone Generic Now Approved: Glatopa May Reduce Treatment Costs

    May 01, 2015

    Multiple sclerosis (MS) is a debilitating autoimmune disease that currently does not have a cure. It affects around 400,000 people in the United States alone, with symptoms presenting most often between 20 and 40 years of age.

    Copaxone (glatiramer acetate), one of the most popular treatments for multiple sclerosis, has recently received generic FDA approval under the name Glatopa.

    The FDA approval of Glatopa is a big deal for patients being treated for MS, especially since medication costs for this condition are nearing $60,000 a year. See More

see all savings tips

Popular Multiple Sclerosis Drugs

Popularity Drug Name Drug Class Price
Corticosteroids 5 See Prices
GABA Agonists 12 See Prices
GABA Agonists 12 See Prices
see all 37 drugs

Note: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.

Multiple Sclerosis Drug Classes

Copyright ©2016 GoodRx, Inc.

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.